Ligand-targeted therapeutics in anticancer therapy.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 750, doi. 10.1038/nrc903
- By:
- Publication type:
- Article
Works matching IS 1474175X AND DT 2002 AND VI 2 AND IP 10
Results: 20
1
2
c-myc: more than just a matter of life and death.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 764, doi. 10.1038/nrc904
- By:
- Publication type:
- Article
3
Clinical translation of angiogenesis inhibitors.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 727, doi. 10.1038/nrc905
- By:
- Publication type:
- Article
4
Transcription factors as targets for cancer therapy.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 740, doi. 10.1038/nrc906
- By:
- Publication type:
- Article
5
Deregulated homeobox gene expression in cancer: cause or consequence?
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 777, doi. 10.1038/nrc907
- By:
- Publication type:
- Article
6
Opinion: Anti-oestrogenic prevention of breast cancer — the make or break point.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 787, doi. 10.1038/nrc908
- By:
- Publication type:
- Article
7
Timeline: VEGF and the quest for tumour angiogenesis factors.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 795, doi. 10.1038/nrc909
- By:
- Publication type:
- Article
8
DNA Repair: Small cause, large effect.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 720, doi. 10.1038/nrc910
- By:
- Publication type:
- Article
9
Cell Proliferation: Dual control.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 725, doi. 10.1038/nrc911
- By:
- Publication type:
- Article
10
Drug Metabolism: Not so innocent.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 720, doi. 10.1038/nrc912
- By:
- Publication type:
- Article
11
Techniques: Welcome interference.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 724, doi. 10.1038/nrc913
- By:
- Publication type:
- Article
12
Reviews and comment from the nature publishing group.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 804, doi. 10.1038/nrc915
- Publication type:
- Article
13
Mouse Models: One step closer...
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 723, doi. 10.1038/nrc916
- By:
- Publication type:
- Article
14
In Brief.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 721
- By:
- Publication type:
- Article
15
In The News: Caffeine — a new cancer cure?
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 720, doi. 10.1038/nrc918
- By:
- Publication type:
- Article
16
Signalling: Fuzzy logic.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 724, doi. 10.1038/nrc919
- By:
- Publication type:
- Article
17
Tumour Suppressors: Mystery molecule.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 719, doi. 10.1038/nrc920
- By:
- Publication type:
- Article
18
Apoptosis: Death-defining feat.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 722, doi. 10.1038/nrc921
- By:
- Publication type:
- Article
19
Therapeutics: Self destruction.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 722, doi. 10.1038/nrc922
- By:
- Publication type:
- Article
20
Trial watch.
- Published in:
- Nature Reviews Cancer, 2002, v. 2, n. 10, p. 723
- Publication type:
- Article